Editorial
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista Científica da Faculdade de Medicina de Campos |
Texto Completo: | https://revista.fmc.br/ojs/index.php/RCFMC/article/view/1042 |
Resumo: | The conclusion of a cycle creates opportunities for reflection, whose purpose is improvement, and in the Scientific Journal of the Faculty of Medicine of Campos (RCFMC), this has manifested in increased views and submissions, reduced response times for authors, and a decrease in scientific endogamy, favoring the exchange of ideas and the circulation of knowledge among institutions. In this year of significant achievements, we reach the end of 2023 with the second issue of volume 18 of RCFMC, representing the multidisciplinary field of health sciences, biological sciences, and related areas with the publication of nine articles: an original article that identified the impacts of the COVID-19 pandemic and remote learning on the learning of medical students at a private university center; five review articles, including one addressing signs, symptoms, diagnosis, and treatment of mucopolysaccharidosis type II, another describing the role of Primary Health Care in the context of pregnancy and domestic violence, another discussing comorbidities associated with low serum levels of adiponectin in obese individuals, the use of this molecule as a predictive biomarker for metabolic syndrome, endothelial alterations, dyslipidemia, and atherosclerosis in eutrophic and obese individuals, as well as the perspective of its potential therapeutic target; another presenting the benefits and challenges of implementing pharmacogenetic and pharmacogenomic tests in clinical practice; and the use of hydrochlorothiazide, a drug intended for the treatment of arterial hypertension and erectile dysfunction; finally, three case reports, one diagnosing pulmonary embolism assisted by alterations in transthoracic echocardiography during an investigation of syncope, another reporting a case of cutaneous T-cell lymphoma strongly suggestive of Sézary Syndrome, and another describing a case of cerebellar hemangioblastoma associated with Von Hippel-Lindau syndrome. Still motivated by the transformative actions of the previous administration, we continue the task of maintaining the standard of excellence, achieving goals, and attaining objectives in this approaching new cycle. We now arrive at this Editorial moment dedicated to expressions of gratitude: to the authors who shared their research; to the reviewers (anonymous protagonists) and editors who impartially safeguarded the quality of publications; to the Technical Team for their dedication and valuable contribution; and finally, to our readers, the primary reason for our work. |
id |
FMC-0_4fb92a7579b91995caa57f894c405cb9 |
---|---|
oai_identifier_str |
oai:ojs2.revista.fmc.br:article/1042 |
network_acronym_str |
FMC-0 |
network_name_str |
Revista Científica da Faculdade de Medicina de Campos |
repository_id_str |
|
spelling |
EditorialEditorial The conclusion of a cycle creates opportunities for reflection, whose purpose is improvement, and in the Scientific Journal of the Faculty of Medicine of Campos (RCFMC), this has manifested in increased views and submissions, reduced response times for authors, and a decrease in scientific endogamy, favoring the exchange of ideas and the circulation of knowledge among institutions. In this year of significant achievements, we reach the end of 2023 with the second issue of volume 18 of RCFMC, representing the multidisciplinary field of health sciences, biological sciences, and related areas with the publication of nine articles: an original article that identified the impacts of the COVID-19 pandemic and remote learning on the learning of medical students at a private university center; five review articles, including one addressing signs, symptoms, diagnosis, and treatment of mucopolysaccharidosis type II, another describing the role of Primary Health Care in the context of pregnancy and domestic violence, another discussing comorbidities associated with low serum levels of adiponectin in obese individuals, the use of this molecule as a predictive biomarker for metabolic syndrome, endothelial alterations, dyslipidemia, and atherosclerosis in eutrophic and obese individuals, as well as the perspective of its potential therapeutic target; another presenting the benefits and challenges of implementing pharmacogenetic and pharmacogenomic tests in clinical practice; and the use of hydrochlorothiazide, a drug intended for the treatment of arterial hypertension and erectile dysfunction; finally, three case reports, one diagnosing pulmonary embolism assisted by alterations in transthoracic echocardiography during an investigation of syncope, another reporting a case of cutaneous T-cell lymphoma strongly suggestive of Sézary Syndrome, and another describing a case of cerebellar hemangioblastoma associated with Von Hippel-Lindau syndrome. Still motivated by the transformative actions of the previous administration, we continue the task of maintaining the standard of excellence, achieving goals, and attaining objectives in this approaching new cycle. We now arrive at this Editorial moment dedicated to expressions of gratitude: to the authors who shared their research; to the reviewers (anonymous protagonists) and editors who impartially safeguarded the quality of publications; to the Technical Team for their dedication and valuable contribution; and finally, to our readers, the primary reason for our work. O encerramento de um ciclo cria oportunidades para reflexão, cujo propósito é o aprimoramento, que, na Revista Científica da Faculdade de Medicina de Campos (RCFMC), se revelou com o aumento das visualizações e submissões, com a redução do tempo de resposta para os autores e com a diminuição da endogenia científica, favorecendo a troca de ideias e a circulação de conhecimento entre instituições. Neste ano de significativas realizações, chegamos ao final de 2023 com o segundo número do volume 18 da RCFMC, que expressa o campo multidisciplinar das áreas das ciências da saúde, ciências biológicas e áreas correlatas com a publicação de nove artigos: um artigo original, que identificou os impactos da pandemia de COVID-19 e do ensino remoto no aprendizado por estudantes de medicina de um centro universitário privado; cinco artigos de revisão, entre os quais, um abordou sinais, sintomas, diagnóstico e tratamento da mucopolissacaridose tipo II, outro que descreveu o papel da Atenção Primária à Saúde no contexto da gravidez e violência doméstica, outro referiu à comorbidades associadas aos baixos níveis séricos de adiponectina em indivíduos obesos, o uso dessa molécula como biomarcador preditivo para síndrome metabólica, alterações endoteliais, dislipidemia e aterosclerose em eutróficos e obesos, assim como, a perspectiva de seu potencial alvo terapêutico, outro que apresentou os benefícios e os desafios para a implantação dos testes farmacogenéticos e farmacogenômicos na prática clínica e O uso de hidroclorotiazida, fármaco destinado ao tratamento da hipertensão arterial, e a disfunção erétil, por fim, três relatos de caso, sendo um de diagnóstico de tromboembolismo pulmonar auxiliado por alterações no ecocardiograma transtorácico, durante uma investigação de síncope, outro que relatou um caso de linfoma cutâneo de células T fortemente sugestivo para Síndrome de Sézary, e outro, que descreveu um caso de hemangioblastoma cerebelar associado à síndrome de Von Hippel-Lindau. Ainda motivados pelas ações transformadoras da gestão anterior, prosseguirmos com a tarefa de manter o padrão de excelência, de alcançar metas e conquistar objetivos neste novo ciclo que se aproxima. Chegamos ao momento desde Editorial dedicado aos agradecimentos: aos autores que compartilharam suas pesquisas; aos pareceristas (protagonistas anônimos) e editores que, de modo imparcial, zelaram pela qualidade das publicações; à Equipe Técnica pela dedicação e valiosa contribuição e, finalmente, aos nossos leitores, principal motivo do nosso trabalho.Faculdade de Medicina de Campos (FMC)2023-12-26info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revista.fmc.br/ojs/index.php/RCFMC/article/view/1042Scientific Journal of the Medical School of Campos; Vol. 18 No. 2 (2023): Revista Científica da Faculdade de Medicina de Campos; 1Revista Científica da Faculdade de Medicina de Campos; v. 18 n. 2 (2023): Revista Científica da Faculdade de Medicina de Campos; 12965-65751980-7813reponame:Revista Científica da Faculdade de Medicina de Camposinstname:Faculdade de Medicina de Campos (FMC)instacron:FMCporhttps://revista.fmc.br/ojs/index.php/RCFMC/article/view/1042/425Copyright (c) 2023 Revista Científica da Faculdade de Medicina de Camposhttps://creativecommons.org/licenses/by-sa/4.0info:eu-repo/semantics/openAccessSilva, Valmir Laurentino2023-12-26T20:28:40Zoai:ojs2.revista.fmc.br:article/1042Revistahttps://www.fmc.br/ojs/index.php/RCFMC/PRIhttps://www.fmc.br/ojs/index.php/RCFMC/oai||revista@fmc.br1980-78131980-7813opendoar:2023-12-26T20:28:40Revista Científica da Faculdade de Medicina de Campos - Faculdade de Medicina de Campos (FMC)false |
dc.title.none.fl_str_mv |
Editorial |
title |
Editorial |
spellingShingle |
Editorial Silva, Valmir Laurentino Editorial |
title_short |
Editorial |
title_full |
Editorial |
title_fullStr |
Editorial |
title_full_unstemmed |
Editorial |
title_sort |
Editorial |
author |
Silva, Valmir Laurentino |
author_facet |
Silva, Valmir Laurentino |
author_role |
author |
dc.contributor.author.fl_str_mv |
Silva, Valmir Laurentino |
dc.subject.por.fl_str_mv |
Editorial |
topic |
Editorial |
description |
The conclusion of a cycle creates opportunities for reflection, whose purpose is improvement, and in the Scientific Journal of the Faculty of Medicine of Campos (RCFMC), this has manifested in increased views and submissions, reduced response times for authors, and a decrease in scientific endogamy, favoring the exchange of ideas and the circulation of knowledge among institutions. In this year of significant achievements, we reach the end of 2023 with the second issue of volume 18 of RCFMC, representing the multidisciplinary field of health sciences, biological sciences, and related areas with the publication of nine articles: an original article that identified the impacts of the COVID-19 pandemic and remote learning on the learning of medical students at a private university center; five review articles, including one addressing signs, symptoms, diagnosis, and treatment of mucopolysaccharidosis type II, another describing the role of Primary Health Care in the context of pregnancy and domestic violence, another discussing comorbidities associated with low serum levels of adiponectin in obese individuals, the use of this molecule as a predictive biomarker for metabolic syndrome, endothelial alterations, dyslipidemia, and atherosclerosis in eutrophic and obese individuals, as well as the perspective of its potential therapeutic target; another presenting the benefits and challenges of implementing pharmacogenetic and pharmacogenomic tests in clinical practice; and the use of hydrochlorothiazide, a drug intended for the treatment of arterial hypertension and erectile dysfunction; finally, three case reports, one diagnosing pulmonary embolism assisted by alterations in transthoracic echocardiography during an investigation of syncope, another reporting a case of cutaneous T-cell lymphoma strongly suggestive of Sézary Syndrome, and another describing a case of cerebellar hemangioblastoma associated with Von Hippel-Lindau syndrome. Still motivated by the transformative actions of the previous administration, we continue the task of maintaining the standard of excellence, achieving goals, and attaining objectives in this approaching new cycle. We now arrive at this Editorial moment dedicated to expressions of gratitude: to the authors who shared their research; to the reviewers (anonymous protagonists) and editors who impartially safeguarded the quality of publications; to the Technical Team for their dedication and valuable contribution; and finally, to our readers, the primary reason for our work. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-12-26 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://revista.fmc.br/ojs/index.php/RCFMC/article/view/1042 |
url |
https://revista.fmc.br/ojs/index.php/RCFMC/article/view/1042 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://revista.fmc.br/ojs/index.php/RCFMC/article/view/1042/425 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Revista Científica da Faculdade de Medicina de Campos https://creativecommons.org/licenses/by-sa/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Revista Científica da Faculdade de Medicina de Campos https://creativecommons.org/licenses/by-sa/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Faculdade de Medicina de Campos (FMC) |
publisher.none.fl_str_mv |
Faculdade de Medicina de Campos (FMC) |
dc.source.none.fl_str_mv |
Scientific Journal of the Medical School of Campos; Vol. 18 No. 2 (2023): Revista Científica da Faculdade de Medicina de Campos; 1 Revista Científica da Faculdade de Medicina de Campos; v. 18 n. 2 (2023): Revista Científica da Faculdade de Medicina de Campos; 1 2965-6575 1980-7813 reponame:Revista Científica da Faculdade de Medicina de Campos instname:Faculdade de Medicina de Campos (FMC) instacron:FMC |
instname_str |
Faculdade de Medicina de Campos (FMC) |
instacron_str |
FMC |
institution |
FMC |
reponame_str |
Revista Científica da Faculdade de Medicina de Campos |
collection |
Revista Científica da Faculdade de Medicina de Campos |
repository.name.fl_str_mv |
Revista Científica da Faculdade de Medicina de Campos - Faculdade de Medicina de Campos (FMC) |
repository.mail.fl_str_mv |
||revista@fmc.br |
_version_ |
1798042300929015808 |